1,184 research outputs found
Low implantation depth during TAVR increases the pressure exerted on the atrioventricular conduction system: a biomechanical analysis
Enabling automated device size selection for transcatheter aortic valve implantation
The number of transcatheter aortic valve implantation (TAVI) procedures is expected to increase significantly in the coming years. Improving efficiency will become essential for experienced operators performing large TAVI volumes, while new operators will require training and may benefit from accurate support. In this work, we present a fast deep learning method that can predict aortic annulus perimeter and area automatically from aortic annular plane images. We propose a method combining two deep convolutional neural networks followed by a postprocessing step. The models were trained with 355 patients using modern deep learning techniques, and the method was evaluated on another 118 patients. The method was validated against an interoperator variability study of the same 118 patients. The differences between the manually obtained aortic annulus measurements and the automatic predictions were similar to the differences between two independent observers (paired diff. of 3.3 +/- 16.8 mm(2) vs. 1.3 +/- 21.1 mm(2) for the area and a paired diff. of 0.6 +/- 1.7 mm vs. 0.2 +/- 2.5 mm for the perimeter). The area and perimeter were used to retrieve the suggested prosthesis sizes for the Edwards Sapien 3 and the Medtronic Evolut device retrospectively. The automatically obtained device size selections accorded well with the device sizes selected by operator 1. The total analysis time from aortic annular plane to prosthesis size was below one second. This study showed that automated TAVI device size selection using the proposed method is fast, accurate, and reproducible. Comparison with the interobserver variability has shown the reliability of the strategy, and embedding this tool based on deep learning in the preoperative planning routine has the potential to increase the efficiency while ensuring accuracy
Infrared spectral analysis for the classification of patients with acute coronary syndrome. The questions run so deep
Artificial intelligence and transcatheter aortic valve implantation-induced conduction disturbances-adding insight beyond the human 'I'
Mrs. Smith, an active 83-year-old female with a medical history encompassing hypertension and type 2 diabetes mellitus, presents with symptomatic severe aortic valve stenosis. Her left ventricular function is normal, and there is no evidence of obstructive coronary artery disease. She undergoes a transcatheter aortic valve implantation (TAVI) with a 34 mm self-expandable prosthesis. According to the interventional cardiologist, the procedure was uncomplicated, thereby considering the post-operative left bundle branch block (LBBB) as trivial. As a 5-day post-operative continuous rhythm monitoring reveals no other conduction abnormality or delay, Mrs. Smith is discharged home with a persistent LBBB. However, 2 weeks later, she is re-admitted due to a cardiac syncope attributed to high-grade atrioventricular block (HAVB), necessitating permanent pacemaker implantation (PPMI)
Multislice computer tomography (MSCT) for the optimisation of transcatheter aortic valve implantation (TAVI)
Transcatheter aortic valve replacement (TAVI) is a novel therapy that is increasingly used to treat patients with severe aortic stenosis at high risk for surgical valve replacement. Patient selection, procedural planning and evaluation all require a detailed analysis of patient anatomy. The role and added value of multislice computer tomography (MSCT) is described as a 3-D imaging modality that enables a comprehensive evaluation of the complex 3-D anatomy of the aortic root, planning of all potential transcatheter access routes and evaluation of prosthesis anatomy interactions post-implantation
Case report: Concomitant MitraClip implantation for severe mitral regurgitation and plug closure of endocarditis induced fistula between aortic root and left atrium after transcatheter aortic valve implantation
Background: Infective endocarditis (IE) after transcatheter aortic valve implantation (TAVI) occurs in up to 1.5% of patients within the first year. The development of an aorto-atrial fistula (AAF) is a rare but problematic complication of IE, which can be confirmed with transoesophageal echocardiography (TOE). We present an exceptional case of occluding an aorto-left atrial fistula only diagnosed with intraprocedural TOE during a subsequent procedure of MitraClip implantation. Case summary: A 79-year-old symptomatic male patient with multiple comorbidities was referred due to severe mitral regurgitation (MR). He has had prior TAVI which was complicated with streptococcal IE for which he had received prolonged antibacterial therapy. Transthoracic echocardiography (TTE) revealed severe MR. The patient was accepted for a MitraClip procedure by the heart team. Intra-procedural TOE revealed also a significant continuous shunt through an AAF which was likely caused by the endocarditis. The strategy was therefore defined as to occlude the fistula with an Amplatzer Vascular Plug II 12 mm. The plug was released in the fistula leaving an insignificant residual shunt. After the transseptal puncture one MitraClip XTR was implanted, reducing the MR to mild. After the procedure, the patient's general clinical condition improved without signs of haemolysis. The pre-discharge TTE confirmed trace residual shunt, mild residual MR and mild paravalvular leakage. Discussion: Our case illustrates a complex transcatheter structural heart intervention with improvised procedural strategies based on the intra-procedural TOE findings. We conclude that the pre-procedural TOE needs to be comprehensive rather than exclusive, particularly in the context of bioprosthesis-related endocarditis
Endotracheal instillation of prostacyclin in preterm infants with persistent pulmonary hypertension
Does endotracheal instilled prostacyclin (epoprostenol) improve
oxygenation in preterm infants with persistent pulmonary hypertension?
Four preterm infants were studied. Prostacyclin (50 ng x kg(-1)) was
injected as an endotracheal bolus. In two patients the prostacyclin bolus
was repeated and in one patient prostacyclin was administered
continuously. Oxygenation was evaluated through the oxygenation index and
the ratio of arterial oxygen tension to the fraction of inspired oxygen.
The mean arterial blood pressure was used to evaluate systemic
circulation. The oxygenation index (+/-SD) decreased significantly from 39
(+/-13.3) to 7 (+/-2.5) and the ratio of arterial oxygen tension to the
fraction of inspired oxygen (+/-SD) increased significantly from 47
(+/-13) to 218 (+/-67), most likely related to a reduction of the
pulmonary vascular resistance with a reversal of the extrapulmonary
shunting at the ductus arteriosus and atrial level. The blood pressure did
not change. All effects were reversed on drug withdrawal. Repeated or
continuous endotracheal administration of prostacyclin in three children
demonstrated a sustained response without tachyphylaxis, and without overt
side-effects. Endotracheal instillation of prostacyclin resulted in an
improved oxygenation without systemic vascular repercussions in four
preterm infants with persistent pulmonary hypertension. Repeated or
continuous administration showed a sustained response and no overt
side-effects were noticed
- …